Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation

被引：0
|
作者：
Fahad Shaikh
Lachlan B. Pasch
Phillip J. Newton
Beata V. Bajorek
Caleb Ferguson
机构：
[1] University of Technology Sydney,Discipline of Pharmacy, Graduate School of Health
[2] Western Sydney Nursing and Midwifery Research Centre,undefined
[3] Western Sydney Local Health District and Western Sydney University,undefined
[4] Blacktown Clinical and Research School,undefined
[5] Blacktown Hospital,undefined
来源：
Current Cardiology Reports | 2018年 / 20卷
关键词：
Atrial fibrillation; Multimorbidity; Polypharmacy; Anticoagulation; Warfarin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] ADDRESSING POLYPHARMACY Reply
    Chou, Joshua
    Tong, Monica
    Brandt, Nicole J.
    JOURNAL OF GERONTOLOGICAL NURSING, 2019, 45 (06): : 6 - 7
  • [32] Addressing the Challenge of Polypharmacy
    Mair, Alpana
    Wilson, Martin
    Dreischulte, Tobias
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60, 2020, 60 : 661 - 681
  • [33] Managing elderly patients with atrial fibrillation and multimorbidity: call for a systematic approach
    van Deutekom, Colinda
    Hendriks, Jeroen M. L.
    Myrstad, Marius
    Van Gelder, Isabelle C.
    Rienstra, Michiel
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2024, 22 (10) : 523 - 536
  • [34] Multimorbidity in atrial fibrillation: A call for integrated patient-centered care
    Boriani, Giuseppe
    Mei, Davide Antonio
    Imberti, Jacopo Francesco
    KARDIOLOGIA POLSKA, 2023, 81 (06) : 560 - 562
  • [35] Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
    Van Deutekom, Colinda
    Geelhoed, Bastiaan
    Van Munster, Barbara C.
    Bakker, Stephan J. L.
    Gansevoort, Ron T.
    Van Gelder, Isabelle C.
    Rienstra, Michiel
    OPEN HEART, 2023, 10 (02):
  • [36] Cardiometabolic multimorbidity and lifetime risk of atrial fibrillation among men and women
    Lu, Z.
    Ntlapto, N.
    Tilly, M.
    Ikram, M. A.
    De Groot, N. M. S.
    Kavousi, M.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2241 - 2241
  • [37] Multimorbidity in atrial fibrillation for clinical implications using the Charlson Comorbidity Index
    Jung, Moonki
    Yang, Pil -Sung
    Kim, Daehoon
    Sung, Jung-Hoon
    Jang, Eunsun
    Yu, Hee Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Pak, Hui -Nam
    Lee, Moon-Hyoung
    Joung, Boyoung
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 398
  • [38] Multimorbidity, polypharmacy and pharmacogenomics in old age
    Brockmoeller, Juergen
    Stingl, Julia C.
    PHARMACOGENOMICS, 2017, 18 (06) : 515 - 517
  • [39] Risk of atrial fibrillation in individuals with dysglycemia and diabetes
    Rorth, Rasmus
    Kriegbaum, Margit
    Grand, Mia Klinten
    Jacobsen, Peter Karl
    Lind, Bent Struer
    Andersen, Christen Lykkegaard
    Persson, Frederik
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (09)
  • [40] The "Double" Paradox of Atrial Fibrillation in Black Individuals
    Stamos, Thomas D.
    Darbar, Dawood
    JAMA CARDIOLOGY, 2016, 1 (04) : 377 - 379
12345